• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

patient stratification

Sonde Health Secures $19.25M for Voice-Based Health Monitoring

by Fred Pennic 12/08/2022 Leave a Comment

Sonde Health Secures $19.25M for AI Vocal Biomarker Platform

What You Should Know: - Sonde Health, a Boston, MA-based health technology company committed to bringing accessible health monitoring to everyone raises $19.25 million in a Series B investment round led by Partners Investment, with participation from NEOM Company, KT Corporation, and existing investors, including co-founder PureTech Health and M Ventures. - The AI vocal biomarker company will use the funding to accelerate its commercial growth, expand its platform into new health
Read More

NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers

by Syed Hamza Sohail 07/28/2022 Leave a Comment

NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers

What You Should Know: - NeuroSense Therapeutics Ltd., a company developing treatments for severe neurodegenerative diseases, and NeuraLight, a company developing objective and sensitive biomarkers for neurological disorders, today announced a collaboration to advance the science of digital biomarkers in the detection and monitoring of neurological diseases including amyotrophic lateral sclerosis (ALS). - This agreement marks NeuraLight’s first clinical trial and comes on the heels of
Read More

Embright Taps Innovaccer to Advance Population Health Initiatives

by Jasmine Pennic 09/24/2020 Leave a Comment

Embright Taps Innovaccer to Advance Population Health Initiatives

What You Should Know:  -Clinically integrated network (CIN) Embright selects Innovaccer to advance population health initiatives across its network.  -  The clinically integrated network will leverage Innovaccer’s Data Activation Platform to track its overall performance and address patient healthcare needs. Innovaccer, Inc., a healthcare technology company, today announced it has partnered with Embright, a Pacific Northwest-based clinically integrated network (CIN) founded by UW
Read More

Innovaccer Launches Perioperative Optimization Platform for Surgeons

by Jasmine Pennic 08/18/2020 Leave a Comment

Innovaccer Launches Perioperative Optimization Platform for Surgeons

What You Should Know: - Innovaccer launches a perioperative optimization solution for surgeons to realize clinical and financial goals with patient-risk analysis. - The solution redefines surgical planning and post-surgical recovery with machine learning-based patient stratification for optimized surgery experience and personalized patient care management. Innovaccer, Inc., a San Francisco, CA-based healthcare technology company, recently launched its perioperative optimization
Read More

TeraRecon Acquired by SymphonyAI: What is the Impact for Medical Imaging Market?

by Simon Harris, Managing Director at Signify Research 03/09/2020 Leave a Comment

TeraRecon Acquired by SymphonyAI: What is the Impact for Medical Imaging Market?

On the 4th March 2020, TeraRecon announced it had signed an agreement to be acquired by the SymphonyAI Group. Here are the facts of the deal, followed by our take on the potential impact on the medical imaging market: - The terms of the deal were not disclosed and TeraRecon will continue to operate business as usual. However, it will benefit from greater financial backing and the synergistic technologies from other companies in the Group’s portfolio. - TeraRecon is an Advanced
Read More

The Many Faces of AI in Clinical Trials

by Dr. Ulrik Kristensen, Senior Market Analyst at Signify Research 02/28/2020 Leave a Comment

The Many Faces of AI in Clinical Trials

AI is being applied in several aspects for the clinical trial process today. From analyzing real-world data and scientific information to providing improved patient stratification and predictive outcomes, and assisting with different aspects of clinical trial operations. Here are some of the technologies using AI and machine learning in the clinical trial space today, outlining how they fit within the clinical trial ecosystem and discuss the impact on future clinical trial designs. The
Read More

Why SDoH Data Is Key For Developing Population Health Strategies

by Elizabeth Marshall, MD, MBA, Director of Clinical Analytics at Linguamatics, an IQVIA company 10/16/2019 Leave a Comment

Simplifying Population Health Management and the Identification of Social Determinants with NLP

The healthcare industry has come a long way in its appreciation of non-clinical factors impacting a patient’s overall well-being, such as social determinants of health (SDoH). However, the industry has made less progress when it comes to gathering information on individual patients’ social determinants, analyzing the details and – most importantly – translating the findings into actionable information that healthcare organizations (HCOs) can use to improve population health management. One
Read More

Can Artifical Intelligence Solve The Chronic Kidney Disease Epidemic?

by Girish Nadkarni, MD, Assistant Professor in the Department of Medicine, Division of Nephrology, at Mount Sinai, and Co-Founder of RenalytixAI 06/25/2019 Leave a Comment

Can Artifical Intelligence Solve The Chronic Kidney Disease Epidemic?

Chronic kidney disease (CKD) is a growing epidemic worldwide. Currently, there are 850 million individuals suffering from CKD globally, with 40 million in the United States alone. Of these individuals, 96 percent are not aware of having CKD, as kidney disease often exhibits no symptoms until it has progressed to a late stage. As this epidemic continues to grow, healthcare providers and organizations are working to determine how artificial intelligence (AI) can be used to analyze electronic
Read More

3 Keys to Scaling Up Population Health Management for Providers

by Fred Pennic 05/26/2016 Leave a Comment

3 Keys to Scaling Up Population Health Management for Providers

Financial incentives, technological advances and pioneering care models have provided fertile soil for the green shoots of population health to grow. But for these programs to flourish, they will need more sophisticated analytics, patient stratification, community involvement and care management.This week, PwC’s Health Research Institute (HRI) released “Population health: Scaling up,” where they interviewed executives in leading healthcare, research and academic institutions on how organizations
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

GE HealthCare to Acquire Caption Health

GE HealthCare to Acquire Caption Health to Expand AI-Guided Ultrasounds

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |